TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Merit Medical Systems ( (MMSI) ) is now available.
Merit Medical Systems announced on November 13, 2025, that the U.S. Centers for Medicare & Medicaid Services deferred its application for Transitional Pass-Through payment for its WRAPSODY® Cell-Impermeable Endoprosthesis to the 2027 Outpatient Prospective Payment System rule. Despite this setback, Merit plans to pivot strategically by withdrawing the application and commencing full commercialization of the product in the U.S. immediately. This move aims to enhance patient access and optimize the adoption of the technology, which has shown promising clinical evidence in trials. The company forecasts U.S. revenue from WRAPSODY CIE sales to range between $2 million and $4 million for 2025.
The most recent analyst rating on (MMSI) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
Merit Medical Systems’ overall stock score is driven by its strong financial performance and positive earnings call, highlighting robust revenue growth and strategic initiatives. However, the high P/E ratio suggests overvaluation, and technical indicators point to potential resistance in the long term.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.
Average Trading Volume: 607,678
Technical Sentiment Signal: Hold
Current Market Cap: $5.22B
Find detailed analytics on MMSI stock on TipRanks’ Stock Analysis page.